Tech Firm Releases Telemedicine Product Aiding Senior Care, Safety
Source: Streetwise Reports  (10/28/19)
The package encompasses wearable devices, two-way video communication and geofencing. More >

IVERIC bio Shares Double After Announcing Phase 2b AMD Topline Data
Source: Streetwise Reports  (10/28/19)
Shares of IVERIC bio opened nearly 100% higher today after reporting that it successfully met its primary endpoint in its Phase 2b age-related macular degeneration study for Zimura. More >

ResMed Shares Set 52-Week Intraday High Price After Posting Q1 Earnings
Source: Streetwise Reports  (10/25/19)
Shares of respiratory medical device maker and software applications company ResMed Inc. traded 15% higher at times today after the firm posted positive Q1/20 earnings results. More >

Varian Shares Trade Higher on Yearly Earnings and FY/20 Guidance
Source: Streetwise Reports  (10/24/19)
Shares of Varian Medical Systems traded 10% higher at times today after the company reported quarterly and annual earnings. The company increased revenue 10% year-over-year and provided FY/20 guidance. More >

Biotech's Topline Phase 3 HER2-Positive Breast Cancer Data 'Impresses'
Source: Streetwise Reports  (10/23/19)
The results and commercial potential of the therapeutic are discussed in an H.C. Wainwright & Co. report. More >

Mobile Health Solutions Provider Adds Clients in Multiple States, Verticals
Source: Streetwise Reports  (10/23/19)
The primary aim of the firm's technology platform is to support remote patient monitoring. More >

Biotech Develops Antibodies Targeting TDP-43 in Neurodegenerative Diseases
Source: Streetwise Reports  (10/23/19)
These therapeutic candidates add to those already in the firm's pipeline. More >

Boston Scientific Reports 13% Q3 Sales Growth and Raises Yearly Estimates
Source: Streetwise Reports  (10/23/19)
This morning shares of Boston Scientific traded 6% higher after the firm reported a 13.1% increase in revenue for Q3/19. The firm also raised its revenue guidance for both Q4/19 and FY/19. More >

Biogen Shares Rebound Strongly on Updated Phase 3 Alzheimer's Data and Q3 Earnings
Source: Streetwise Reports  (10/22/19)
Shares of Biogen Inc. opened nearly 39% higher today after the firm announced plans to submit a Biologics License Application to the FDA in early 2020 for its Alzheimer's drug aducanumab based on new analysis of larger datasets from two phase 3 studies. The company also announced Q3/19 earnings today. More >

Clinical Trial Starts for Biopharma's Antifungal in Cryptococcal Meningitis
Source: Streetwise Reports  (10/21/19)
The details of this study and a second one are outlined in a ROTH Capital Partners report. More >

Dermira's Phase 2b Atopic Dermatitis Trial Results Send Shares 25% Higher
Source: Streetwise Reports  (10/18/19)
Dermira shares traded higher today after the firm released positive data from its phase 2b study of lebrikizumab in patients with atopic dermatitis at the Las Vegas Fall Clinical Dermatology Conference. More >

Protalix Shares Trade up 70% Upon Release of Phase 3 Fabry Disease Data
Source: Streetwise Reports  (10/17/19)
Shares of Protalix Biotherapeutics skyrocketed today on much higher than average volume as the firm announced positive 12-month interim data from its BRIDGE Phase 3 open label switch-over study of pegunigalsidase alfa (PRX-102) for the treatment of Fabry disease. More >

Healthcare Tech Firm Signs Five New Clients in Texas
Source: Streetwise Reports  (10/16/19)
The company just landed another five clients in Texas and now plans to build out sales teams in five additional states. More >

Achillion Pharma Shares Open 75% Higher After Alexion Buyout Offer
Source: Streetwise Reports  (10/16/19)
Shares of Achillion Pharmaceuticals are trading much higher today after the firm reported that it has agreed to be acquired by Alexion Pharmaceuticals for $930 million, or $6.30 per share in cash, along with the potential for an additional $2 per share if certain other specific clinical trial and regulatory milestones are met. More >

Assembly Biosciences Stock Sizzles Following Phase 2a Announcement and Buy Rating from Mizuho
Source: Streetwise Reports  (10/16/19)
Good news is piling up for this healthcare stock engaged in the treatment of hepatitis B as it trades at 5X its average volume with a 30% stock price gain over previous close. More >

Healthcare Company to Use IBM's Watson AI in Telemedicine App
Source: Streetwise Reports  (10/15/19)
The goal is to reduce the time healthcare workers spend on mundane tasks and thereby improve patient care. More >

Relmada Therapeutics Stock Soars on Phase 2 Depression Study Results
Source: Streetwise Reports  (10/15/19)
Shares of Relmada Therapeutics have traded wildly today after it announced Phase 2 results for its anti-depressant drug dextromethadone. The firm's shares have traded 100–200% higher today and the stock was halted several times trading due to extreme price volatility. More >

Technical Analyst Expects Health Technologies Firm to Break Higher
Source: Clive Maund for Streetwise Reports  (10/14/19)
Technical analyst Clive Maund outlines the reasons this stock might break higher. More >

Cerecor Shares Rise 13% on Sale of Pediatric Portfolio for $32 Million
Source: Streetwise Reports  (10/14/19)
Shares of Cerecor Inc. are trading higher today after reporting that it will sell its pediatric portfolio to Aytu BioScience for $32 million in a combination cash and stock deal. More >

Technical Analyst: As Antibiotic Resistance Rises, So May the Stock of This Livestock Feed Company
Source: Clive Maund for Streetwise Reports  (10/12/19)
Technical analyst Clive Maund believes this stock could gain traction soon. More >

Reata Pharma Shares Trading Higher After Reacquiring U.S. and Worldwide Licensing Rights
Source: Streetwise Reports  (10/11/19)
Shares of Reata Pharmaceuticals are trading 12% higher today after the firm announced it had reacquired all licensing rights in the U.S. for bardoxolone methyl and worldwide rights for omaveloxolone and other next-generation Nrf2 activators from AbbVie. More >

Ra Pharmaceuticals Shares Up 100% Following $2.1 Billion Takeover Bid
Source: Streetwise Reports  (10/10/19)
Shares of Ra Pharmaceuticals doubled today after the firm announced that it will be acquired by Belgian firm UCB for $48 per share in an all cash deal. More >

Soliton Shares Rise on Announcement It Will Report Clinical Data at National Dermatology Conference
Source: Streetwise Reports  (10/9/19)
Soliton Inc. shares traded 10% higher today after advising that later this month it will present the data from clinical trials for its Rapid Acoustic Pulse device used in the treatment of keloid and hypertrophic scars at the American Society for Dermatologic Surgery Annual Meeting. More >

Biopharma Completes Enrollment in Phase 2a Plaque Psoriasis Trial
Source: Streetwise Reports  (10/8/19)
Data from this study should be released by the end of this year. More >

Coverage Initiated on U.S.-Based Precision Therapy Developer
Source: Streetwise Reports  (10/8/19)
The key reasons this story is compelling are given in an H.C. Wainwright & Co. report. More >